New award for melphalan injections with DR. Reddy's laboratories, INC. Ordering period is AUG 31, 2022 - AUG 30, 2023 with four one-year options.

Ended Indefinite Delivery Contract Awarded Last action

Contract number
36E79722D0029
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 100% complete
IDV ceiling
$946,000.00
Award type
Single award
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Veterans Affairs National Acquisition Center awarded an indefinite delivery contract to DR Reddy's Laboratories, Inc. for the delivery of 946 bottles of 50mg Melphalan injections with diluent per year. The single award contract has a potential value of $946,000 over a one-year base period of performance from August 31, 2022 to August 30, 2023, and includes four one-year option periods to extend ordering through August 2027. The originating pre-solicitation notice sought an unrestricted source for Melphalan injections to supply the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service through their respective Pharmaceutical Prime Vendor programs. No set-asides were applied to the award made under solicitation number A36E79722R0014.

The purpose of this contract is to provide an uninterrupted supply of 50mg Melphalan injections with diluent for use across multiple government healthcare agencies. The indefinite delivery contract mechanism establishes pricing and delivery terms that will be ordered via task orders or delivery orders placed during the five-year period of performance as patient needs require. This helps ensure a consistent domestic source of this chemotherapy medication is available for VA, DOD, and other agency patients as needed.

Transactions

Action Obligated Date
Other Administrative Action P00003 · Notification to KTR that first option year will not be exercised. Contract will expire on 8/30/2023. $0
Other Administrative Action P00002 · Incorporation of drug supply chain security act (DSCSA) language $0
Add Subcontract Plan P00001 · Incorporate the 2023 small business subcontracting plan. Plan effective 4/1/2023 - 3/31/2024 $0
Original award $0

Quick answers

Who was awarded contract 36E79722D0029?

36E79722D0029 was awarded to DR Reddy's Laboratories, Inc. by National Acquisition Center (Headquarters) on August 31, 2022.

How much is contract 36E79722D0029 worth?

36E79722D0029's own ceiling is $946,000.

Who can order from contract 36E79722D0029?

36E79722D0029 is a single award indefinite delivery contract.

Was contract 36E79722D0029 competed?

The extent of competition for 36E79722D0029 was full and open competition. The government received 2 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV